Skip to main content
10 May 2024
Last updated:
Wednesday 8 May 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Janssen Oncology: When the data show durable response
Read more
Real-world evidence - the new healthcare currency
Read more
Case study - the merits of adaptive trial design
Read more
The next step for EU health technology assessment
Read more
When is one drug more effective than another?
Read more
Ipsen aspires to role as speciality oncology player
Read more
How Pharma is targeting checkpoint inhibitors
Read more
Progress towards personalised cancer vaccines
Read more
Update on the new EU Clinical Trials Regulation
Read more
New body for regenerative medicine launched
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
34
Page
35
Page
36
Page
37
Current page
38
Page
39
Page
40
Page
41
Page
42
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form